Formylcolchicine bound to lactosaminated serum albumin is a more active antifibrotic agent than free colchicine

Liver fibrosis was induced by chronically (7 weeks) administering CCl 4, to rats. Animals were divided into four groups: (a) controls, (b) treated with CCI, alone, (c) treated with CCl 4 and colchicine and (d) treated with CCl 4 and formyl-colchicine bound to lactosaminated serum albumin (FC-LASA)....

Full description

Saved in:
Bibliographic Details
Published inClinica chimica acta Vol. 254; no. 2; pp. 149 - 157
Main Authors Palmerini, C.A., Saccardi, C., Floridi, A., Arienti, G.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier B.V 29.10.1996
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Liver fibrosis was induced by chronically (7 weeks) administering CCl 4, to rats. Animals were divided into four groups: (a) controls, (b) treated with CCI, alone, (c) treated with CCl 4 and colchicine and (d) treated with CCl 4 and formyl-colchicine bound to lactosaminated serum albumin (FC-LASA). Liver dysfunction was monitored by biochemical tests (alkaline phosphatase [ALP], γ-glutamyltransferase [γGT], aspartate and alanine transaminases [AST and ALT], albumin and total bilirubin). Fibrosis was evaluated by determining hydroxyproline and by microscopic examination. The exposure to CCl 4 produced major alterations of liver structure and collagen deposition. These effects were partially counteracted by colchicine and to a greater extent by FC-LASA. Morphological findings paralleled biochemical data. The information reported here indicates that colchicine has an antifibrotic activity on the liver of intoxicated rats and that FC-LASA is more active than colchicine itself as an antifibrotic agent.
ISSN:0009-8981
1873-3492
DOI:10.1016/0009-8981(96)06381-4